FOXO TECHNOLOGIES INC. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
FOXO TECHNOLOGIES INC. (FOXO) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$132.25 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2022-08-12
- FOXO TECHNOLOGIES INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2022-06-30 was -$132.25K, a 107.12% decline year-over-year.
- FOXO TECHNOLOGIES INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2022-03-31 was -$376.97K, a 107.54% decline year-over-year.
- FOXO TECHNOLOGIES INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2021-12-31 was $1.14M.
- FOXO TECHNOLOGIES INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2021-09-30 was $367.04K.
- FOXO TECHNOLOGIES INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2021 was $4.65M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 8 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | -$132.25K 10-Q · filed 2022-08-12 | -$509.23K 10-Q · filed 2022-08-12 | $631.70K derived: sum of 3 quarters · filed 2022-08-12 | $998.74K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2022-03-31 | -$376.97K 10-Q · filed 2022-05-16 | $763.96K derived: sum of 2 quarters · filed 2022-05-16 | $1.13M derived: sum of 3 quarters · filed 2022-05-16 | $2.99M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $1.51M derived: sum of 2 quarters · filed 2022-03-07 | $3.37M derived: sum of 3 quarters · filed 2022-08-12 | $4.65M 10-K · filed 2022-03-07 | |
| 2021-09-30 | $367.04K 10-Q · filed 2021-11-15 | $2.22M derived: sum of 2 quarters · filed 2022-08-12 | $3.51M 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $1.86M 10-Q · filed 2022-08-12 | $3.14M 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | -$1.78M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |